BAX Financial Facts

Cost of sales: 1.49B
Research and development expenses: 159M
See Full Income Statement

Additional contributed capital: 5.93B
Inventories: 1.57B
See Full Balance Sheet

Baxter (BAX) Earnings

  |   Expand Research on BAX
Next EPS Date 2/1/17 EPS Growth Rate +20.9%
Average EPS % Beat Rate +25.6% Revenue Growth Rate +1.9%
Average % Move 1-Wk after EPS +0.6% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/1/17 Q416 N/A$0.52 N/A N/A$2.65B N/A N/A
10/25/16 Q316 $0.58$0.45 +$0.13$2.56B$2.55B Details
7/26/16 Q216 $0.46$0.40 +$0.06$2.6B$2.52B Details
4/26/16 Q116 $0.36$0.29 +$0.07$2.4B$2.35B Details
2/2/16 Q415 $0.43$0.32 +$0.11$2.6B$2.55B Details
10/27/15 Q315 $0.41$0.29 +$0.12$2.49B$2.46B = Details
7/29/15 Q215 $1.00$0.95 +$0.05$3.9B$3.77B = Details
4/23/15 Q115 $1.00$0.88 +$0.12$3.76B$3.7B = Details